2666 Stock Overview
Offers financing and advisory services in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
Genertec Universal Medical Group Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$4.65 |
| 52 Week High | HK$5.87 |
| 52 Week Low | HK$3.71 |
| Beta | 0.68 |
| 11 Month Change | -5.68% |
| 3 Month Change | 8.90% |
| 1 Year Change | 12.05% |
| 33 Year Change | -14.84% |
| 5 Year Change | -14.68% |
| Change since IPO | -7.00% |
Recent News & Updates
Earnings Working Against Genertec Universal Medical Group Company Limited's (HKG:2666) Share Price
Oct 09
Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year
May 22Recent updates
Earnings Working Against Genertec Universal Medical Group Company Limited's (HKG:2666) Share Price
Oct 09Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year
May 22Genertec Universal Medical Group Company Limited's (HKG:2666) Price Is Right But Growth Is Lacking
May 10Why Investors Shouldn't Be Surprised By Genertec Universal Medical Group Company Limited's (HKG:2666) Low P/E
Feb 05Genertec Universal Medical Group (HKG:2666) Is Reducing Its Dividend To CN¥0.34
Jun 08Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 08Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 31Should You Be Adding Genertec Universal Medical Group (HKG:2666) To Your Watchlist Today?
Aug 20Here's Why We Think Genertec Universal Medical Group (HKG:2666) Is Well Worth Watching
Apr 19Shareholders Of Genertec Universal Medical Group (HKG:2666) Must Be Happy With Their 34% Return
Mar 10Is Genertec Universal Medical Group Company Limited (HKG:2666) Trading At A 48% Discount?
Feb 19Did Genertec Universal Medical Group Company Limited (HKG:2666) Insiders Buy Up More Shares?
Feb 01
The Case For Genertec Universal Medical Group Company Limited (HKG:2666): Could It Be A Nice Addition To Your Dividend Portfolio?
Jan 11What Kind Of Investors Own Most Of Genertec Universal Medical Group Company Limited (HKG:2666)?
Dec 21Reflecting on Genertec Universal Medical Group's (HKG:2666) Share Price Returns Over The Last Three Years
Nov 30Shareholder Returns
| 2666 | HK Diversified Financial | HK Market | |
|---|---|---|---|
| 7D | -3.1% | -1.7% | -0.6% |
| 1Y | 12.0% | -2.8% | 9.6% |
Return vs Industry: 2666 exceeded the Hong Kong Diversified Financial industry which returned -2.8% over the past year.
Return vs Market: 2666 exceeded the Hong Kong Market which returned 9.6% over the past year.
Price Volatility
| 2666 volatility | |
|---|---|
| 2666 Average Weekly Movement | 5.7% |
| Diversified Financial Industry Average Movement | 11.0% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in HK Market | 19.2% |
| 10% least volatile stocks in HK Market | 4.3% |
Stable Share Price: 2666 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 2666's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 21,521 | Wang Wenbing | www.umcare.cn |
Genertec Universal Medical Group Company Limited, together with its subsidiaries, offers financing and advisory services in the People’s Republic of China. It operates in two segments, Finance Business and Healthcare Business. The Finance Business segment provides direct finance leasing; sale and leaseback; factoring; operating leases; and advisory services.
Genertec Universal Medical Group Company Limited Fundamentals Summary
| 2666 fundamental statistics | |
|---|---|
| Market cap | HK$8.80b |
| Earnings (TTM) | HK$2.21b |
| Revenue (TTM) | HK$14.18b |
4.0x
P/E Ratio0.6x
P/S RatioIs 2666 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2666 income statement (TTM) | |
|---|---|
| Revenue | CN¥13.20b |
| Cost of Revenue | CN¥8.89b |
| Gross Profit | CN¥4.31b |
| Other Expenses | CN¥2.25b |
| Earnings | CN¥2.06b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.09 |
| Gross Margin | 32.66% |
| Net Profit Margin | 15.61% |
| Debt/Equity Ratio | 224.9% |
How did 2666 perform over the long term?
See historical performance and comparison